Tianjin Medical University Cancer Insititute & Hospital
Tianjin Medical University Cancer Insititute & Hospital
Tianjin, Tianjin Municipality, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL | Diffuse Large B-Cell Lymphoma-Recurrent; Diffuse Large B-Cell Lymphoma-Refractory | Recruiting | Phase 2 | 2026-08-03 | NCT06570447 | |
| CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-07-29 | NCT07397832 | |
| AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH | Peripheral T-cell Lymphoma Targeted Therapy | Enrolling by invitation | Phase 3 | 2023-01-10 | NCT05678933 |